{
  "id": 12269627,
  "title": "Fidson to produce generic influenza drug, strengthen health security",
  "url": "https://urgent.news/2026/10/06/fidson-to-produce-generic-influenza-drug-strengthen-health-security",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-06T01:04:01.000Z",
  "source": {
    "name": "Punch",
    "slug": "punch",
    "url": "https://punchng.com/fidson-to-produce-generic-influenza-drug-strengthen-health-security/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Fidson Healthcare Plc has been selected to manufacture a generic version of Roche's influenza drug, baloxavir marboxil. The company is one of eleven manufacturers across nine countries to sign sublicense agreements with the Medicines Patent Pool for the development and manufacture of generic versions of the drug.\n\nAccording to Nairametrics, Fidson is among four manufacturers with a global presence and six regionally focused manufacturers. The sublicense agreements mark an important step in strengthening systems and partnerships needed before the next health emergency.\n\nThe generic version of baloxavir marboxil will be supplied to 129 countries, as reported by Punch. The announcement of the sublicensees was made as global leaders gathered at the United Nations General Assembly in New York to discuss pandemic prevention, preparedness and response.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Premium Times",
        "title": "Nigerian drugmaker Fidson selected to manufacture generic influenza antiviral under global licence",
        "url": "https://urgent.news/2026/10/04/nigerian-drugmaker-fidson-selected-to-manufacture-generic-influenza",
        "published": "2026-10-04T10:03:52.000Z"
      },
      {
        "outlet": "Punch Nigeria",
        "title": "Fidson to produce generic influenza drug, strengthen health security",
        "url": "https://urgent.news/2026/10/06/fidson-to-produce-generic-influenza-drug-strengthen-health-security-12271331",
        "published": "2026-10-06T01:04:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}